SCHEMBL29958414

SCHEMBL29958414

OCc1cnc2c(F)c(Br)c(Cl)cc2c1Cl

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDXK O00764 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925739 1.00 PDXK (0.32) PDXK
SCHEMBL28652978 0.82 CSNK2A1 (0.35) —
SCHEMBL29957742 0.73 — —
SCHEMBL22301636 0.73 CYP11B2 (0.35) —
SCHEMBL23926100 0.73 — —
SCHEMBL30721099 0.73 CYP11B2 (0.35) —
SCHEMBL29958587 0.72 TDP1 (0.35) —
SCHEMBL21050694 0.72 TDP1 (0.35) —
SCHEMBL29958391 0.71 KMT2A (0.52) —
SCHEMBL20570729 0.70 MAP3K8 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116390923-A Heterocyclic derivative and preparation method and application thereof 浙江海正药业股份有限公司 2023-07-04 — — CN disclosed
CN-115702025-A Fused tricyclic KRAS inhibitors 因赛特公司 2023-02-14 — — CN disclosed
CN-115124524-A Tricyclic derivative and preparation method and application thereof 浙江海正药业股份有限公司 2022-09-30 — — CN disclosed
WO-2022198905-A1 TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 浙江海正药业股份有限公司 2022-09-29 — — WO disclosed
Send feedback